Open access
900
Views
0
CrossRef citations to date
0
Altmetric
Research Article
ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional decline
Tatsuto Hamatani1 Drug Development Division, Sumitomo Pharma Co., Ltd, Tokyo, Japan;2 Clinical Research, Sumitomo Pharma America, Inc, USACorrespondence[email protected]
View further author information
, View further author information
Naoki Atsuta3 Department of Neurology, Aichi Medical University School of Medicine, Nagakute, JapanView further author information
, Fumiya Sano1 Drug Development Division, Sumitomo Pharma Co., Ltd, Tokyo, JapanView further author information
, Ryoichi Nakamura3 Department of Neurology, Aichi Medical University School of Medicine, Nagakute, JapanView further author information
, Yukikazu Hayashi4 Department of Business Development, A2 Healthcare Corporation, Tokyo, Japan, andView further author information
& Gen Sobue5 Aichi Medical University School of Medicine, Nagakute, JapanView further author information
Pages 388-399
|
Received 07 Sep 2023, Accepted 21 Jan 2024, Published online: 07 Feb 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.